{{Rsnum
|rsid=13016963
|Gene=ALS2CR12
|Chromosome=2
|position=201298088
|Orientation=plus
|GMAF=0.4027
|Gene_s=ALS2CR12
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 19.5 | 44.2 | 36.3
| HCB | 9.0 | 45.5 | 45.5
| JPT | 8.8 | 43.4 | 47.8
| YRI | 17.7 | 49.7 | 32.7
| ASW | 15.8 | 42.1 | 42.1
| CHB | 9.0 | 45.5 | 45.5
| CHD | 7.6 | 47.6 | 44.8
| GIH | 4.0 | 21.8 | 74.3
| LWK | 21.8 | 51.8 | 26.4
| MEX | 17.2 | 51.7 | 31.0
| MKK | 12.2 | 43.6 | 44.2
| TSI | 12.7 | 54.9 | 32.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=22323360
|Title=Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: A meta-analysis of genome-wide association studies
|OA=1
}}
{{PMID Auto GWAS
|PMID=21983787
|Trait=None
|Title=Genome-wide association study identifies three new melanoma susceptibility loci.
|RiskAllele=A
|Pval=9E-10
|OR=1.1400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}